baber/WOPTO huggingface dataset:
Patent IL-109887-A (IL)
Title: Substituted benzoylguanidines, process for their preparation and pharmaceutical compositions containing them
IPC: C07D213/30
Filed: 1994-06-03
Abstract: There are described benzoylguanidines of the formula I <IMAGE>  in which:     R(1) is R(6)-CO or R(7)R(8)N-CO, where R(6), R(7) and R(8) are (perfluoro)alk(en)yl, -(CH)2n-R(9), R(9) is cycloalkyl, phenyl, biphenylyl or naphthyl, where R(7) and R(8) can together be 4 or 5 methylene groups, of which one CH2 group can be replaced by oxygen, S, NH, N-CH3 or N-benzyl; R(2) is defined as R(1), or is H, Hal, CN, NO2, (perfluoro)alk(en)yl, -(CH)2 R(15) where  R(15) is cycloalkyl, phenyl, biphenylyl or naphthyl, or   R(2) is (C1-C9)-heteroaryl, or   R(2) is SR(18), -OR(18), -NR(18)R(19), -CR(18)R(19)R(20);  R(18) = -(CH2)-heteroaryl,  R(19), R(20) are defined as R(18) or are H, (perfluoro)-alkyl, or   R(2) is R(21)-SOm or R(22)R(23)N-SO2-, where R(21) is (perfluoro)alk(en)yl, -CH2-R(24), R(24) is cycloalkyl, phenyl, biphenylyl or naphthyl,  R(22) is H, (perfluoro)alk(en)yl, -(CH2)n-R(29),  R(29) is (C3-C8)-cycloalkyl, phenyl, biphenylyl or naphthyl,  R(23) is H, (perfluoro)alkyl, where R(22) and R(23) can together be 4 or 5 methylene groups, of which one CH2 group can be replaced by oxygen, S, NH, N-CH3 or N-benzyl; or   R(33)X-, where R(2) is  X is oxygen, S, NR(34), (D=O)A-, NR(34)C=MN<(*)>R(35)-, where  M is oxygen, S,  A = oxygen, NR(34),  D = C, SO R(33) and R(35) are (perfluoro)alk(en)yl, -(CH2)n-R(36), where R(36) is cycloalkyl, phenyl, biphenylyl or naphthyl,  R(34) = H, (perfluoro)alkyl, where A and N<(*)> are bonded to the phenyl ring of the benzoylguanidine parent structure; or   R(2) is -SR(40), -OR(40), -NHR(40)R(41), -CHR(40)R(42), <IMAGE>  -C=CR(45) <IMAGE>  where R(40), R(41) are identical or different, and are  -(CH2)p-(CHOH)q-(CH2)r-(CHOH)t-R(51) or  -(CH2)p-O-(CH2-CH2O)q-R(51),  R(51) is hydrogen or methyl, R(42), R(43) are hydrogen or alkyl or, together with the carbon atom carrying them, form a (C3-C8)-cycloalkyl; R(44) is H, (C1-C6)-alkyl, (C3-C8)-cycloalkyl, -CeH2e-R(45) where R(45) is phenyl, heteroaryl or alkyl,  R(46), R(47), R(48), R(49) and R(50) are hydrogen or methyl; or   R(2) is R(55)-NH-SO2-, R(3), R(4) and R(5) are independently of one another defined as R(1) or R(2); and their pharmaceutically tolerable salts.0
Patent IL-110773-A (IL)
Title: 5-arylindole derivatives and pharmaceutical compositions containing them
IPC: A61P9/12
Filed: 1994-08-25
Abstract: wherein A, B, D, E, and F are each independently nitrogen or carbon; R1 is hydrogen, C1 to C6 alkyl, -(CH2)nR7, or C1 to C3 alkyl-aryl; R2, R3, R4, R5 and R6 are each independently hydrogen, C1 to C6 alkyl, aryl, C1 to C3 alkyl-aryl, halogen, cyano, nitro, -(CH2)mNR8R9, -(CH2)mOR9, -SR8, -SO2NR8R9, -(CH2)mNR8SO2R9, -(CH2)mNR8CO2R9, -(CH2)mNR8COR9, -(CH2)mCONR7R9, or -(CH2)mCO2R9; R2 and R3, R3 and R4, R4 and R5, and R5 and R6 may be taken together to form a five- to seven-membered alkyl ring, a six-membered ary ring, a five- to seven-membered heteroalkyl ring, having 1 heteroatom of N, O, or S, or a five- to six-membered heteroaryl ring having 1 or 2 heteroatoms of N, O, or S; R7is -OR10, -SR10, -SO2NR10R11, -NR10SO2R11, -NR10CO2R11, -NR10COR11, -CONR10R11, or -CO2R10; R8, R9, R10 and R11 are each independently hydrogen, C1 to C6alkyl, or C1 to C3 alkyl-aryl; m is 0, 1, or 2; n is 2, 3, or 4; and the above aryl groups and the aryl moieties of the above alkyl-aryl groups are each independently phenyl or substituted phenyl, wherein said substituted phenyl may be substituted with one to three of C1 to C4 alkyl, halogen, hydroxy, cyano, carboxamido, nitro, or C1 to C4 alkoxy, and the pharmaceutically acceptable salts thereof. These compounds are useful in treating migraine and other disorders and are new. These compounds are useful psychotherapeutics and are potent serotonin (5-HT1) agonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain, and chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.
Patent IL-111950-A (IL)
Title: Dynamic aberration corrector for conformal windows
IPC: G02B13/00
Filed: 1994-12-11
Abstract: A system for compensating for optical aberration created by a conformal window (60), the system comprising: one- dimensional corrector plate (32) for providing a varying amount of coma, the corrector plate comprising a plane parallel plate having aspherical surface deviations in one direction, the corrector plate further having an axis of bilateral symmetry, the corrector plate further lacking an axis of rotational symmetry; the corrector plate further capable of being displaced in a direction perpendicular to an optical axis of the system; means (34) for providing a varying amount of astigmatism; and controller means responsive to the optical aberration created by the conformal window and coupled to the one- dimensional corrector plate and to the astigmatism providing means for varying the amount of coma provided by the one- dimensional corrector plate and the amount of astigmatism provided by the astigmatism providing means such that the optical aberration created by the conformal window is minimized.
Patent IL-113474-A (IL)
Title: 1-(arylethynyl)-4-substituted-3-adamantylbenzene derivatives and pharmaceutical and cosmetic compositions containing them
IPC: A61K31/19
Filed: 1995-04-24
Abstract: Bi-aromatic acetylenic cpds. with an adamantyl gp. of formula (I), their chiral analogues and their salts, are new. X = H or halo, R1 = H, -CH3, -CH2-O-R4, -CH2-O-CO-R5, -OR6, -O-(CH2)m-(CO)n-R7, -(CH2)p-CO-R8, -(CH2)p-CO-O-R9 or -S(O)p-R10, Ar = a gp. of formula (a)-(f), R2 = H, halo, 1-20C alkyl, -O-CH2-O-CH2-CH2-O-CH3 or -O-R13, R3 = -O-CH2-O-CH2-CH2-O-CH3, -(Y)n-(CH2)q-R14 or -CH=CH-(CH2)t-R14, m = 1-3, n = 0 or 1, p = 0, 1-3, q = 0, 1-12, t = 0, 1-10, R4, R6, R10 = H or lower alkyl, R5, R12 = lower alkyl, R7 = lower alkyl or a heterocyclic gp., R8 = H, lower alkyl or -N(R')R", R', R" = H, lower alkyl, mono- or poly-hydroxyalkyl, aryl (opt. substd.) or an aminoacid, sugar or peptide residue, or R'+R"= heterocyclic gp., R9 = H, 1-20C alkyl, alkenyl, mono- or poly-hydroxyalkyl, aryl or aralkyl (opt. substd) or a sugar, aminoacid or peptide residue; R11 = H, halo, lower alkyl, hydroxy, -O-R12 or -O-OR12, R13 = H or 1-20C alkyl, R14 = H, lower alkyl, 3-6C cycloaliphatic gp., mono- or poly-hydroxyalkyl, aryl, aralkyl, -CO-R8, -S(O)p-R10, -N(R')R" or, when n = 0, hydroxy, -O-R12 or -O-COR12, Y = O, S or -S(O)p.
Patent IL-123634-A (IL)
Title: Device of miniaturised construction for producing high pressure in a fluid to be atomised
IPC: F16K/
Filed: 1996-10-04
Abstract: A reciprocating pump device for pressurizing fluid, comprising: a cylinder (1); a hollow cylindrical piston (2) having a piston axis reciprocable in said cylinder, said piston providing a path for fluid to flow therethrough, wherein a portion of said piston defines a valve seat; a pressure chamber (4) disposed in said cylinder, wherein fluid flows through said piston into said pressure chamber; a valve member (3) movable by said piston between a closed position in contact with said valve member comprising a surface that engages said valve seat, wherein said valve member is configured so that it cannot rotate about an axis transverse to the piston axis. 990 י" ב בסיון התשס" ד - June 1, 2004
Patent IL-127062-A (IL)
Title: Enhanced production of taxanes by cell cultures of taxus species
IPC: C12N5/00
Filed: 1997-05-27
Abstract: Production of taxanes in high yields in cell culture of a Taxus species comprises: (a) cultivating in suspension, using >= 1 nutrient media (containing an inhibitor of phenylpropanoid metabolism), cells of a Taxus sp. derived from callus or suspension cultures, and (b) recovering >= 1 taxanes from the cells and/or the medium of the cell culture.
Patent IL-128937-A (IL)
Title: Multi functional valve
Inventor: EHRMAN MOSHE
IPC: B60K15/077
Filed: 1999-03-11
Abstract: An over filling and roll over valve includes a housing, in which a valve assembly is located. The valve assembly includes a first stage member and a second stage member, being coaxially and relatively displaceable within the housing. The first stage member has a slit-like aperture at a bottom and an outlet aperture at the top. The inlet and the outlet apertures are in flow communication. The second stage member is a float provided with a flexible membrane strip for closing the slit-like aperture of the first stage member. The valve assembly is provided with at least one anchoring member extending between the first stage member and the second stage member and permitting a limited freedom of relative movement therebetween in such a manner that displacement of the second stage member into its second position entails positive displacement of the first stage member into its second position.
Patent IL-132486-A (IL)
Title: Protection of photocathodes with thin films
IPC: H01J/
Filed: 1998-04-28
Abstract: A thin-film-coated photocathode, comprising a photocathode formed of a first material consisting of potassium cesium antimonide and a thin-film coating of a second material consisting of cesium bromide (CsBr).
Patent IL-136346-A (IL)
Title: Device for centring and positioning a spectacle lens blank
IPC: B23Q3/18
Filed: 2000-05-25
Abstract: Device for centring and positioning a spectacle lens blank in order to place a grinding adapter on that blank, of the type including a support turntable (5) provided with means (32, 38, 39) for holding the blank, characterized in that the holding means include retractable support members (32) on which the blank can be placed and members (38,39) for holding the periphery of the blank which are retractable independently of the support members. 1460 א' בתמוז התשס" ד - June 20, 2004 1461 א' בתמוז התשס" ד - June 20, 2004
Patent IL-145103-A (IL)
Title: High data rate interconnecting device
Inventor: GUROVICH DMITRY
IPC: H01R13/6466
Filed: 2001-08-23
Abstract: An interconnect apparatus for providing a communication path for data signals in a predetermined frequency band, that includes a first and a second sections of a transmission line, connected at one end to first and second data transceiving devices, respectively. A switch, such as a mechanical, electro-mechanical, electronic, electro-magnetic and electro-optical switch, having conductive/non-conductive states, is provided for connecting/disconnecting between the other ends of the first and the second sections, for providing a data communication path between the data transceiving devices while being in its conductive state a third and a fourth sections of a transmission line, each of which connected at one end to a contact of the switch and at the other end to a first and a second connector, respectively. A compensation circuitry is provided for compensating, within the frequency band, parasitic effects caused by the switch and/or cord, while the switch is in its conductive state or, while the switch is in its non-conductive state and while a connection between the first and the second connectors is provided by a cord having predetermined characteristics, such that the compensation circuitry compensates the influence of parasitic effects introduced along the communication path by the switch while being in its non-conductive state and while the cord is a part of the communication path or, by the combination of the third and a fourth sections and the connectors while the switch is in its conductive state.
Patent IL-147493-A (IL)
Title: Methods for reducing the formation of byproducts in the production of recombinant polypeptides
IPC: C12P21/02
Filed: 2002-01-06
Abstract: A method for reducing the formation of a byproduct polypeptide containing an O-acetylserine residue in place of a serine residue by adding at least one of histidine, methionine or glycine to the medium in a method for producing a polypeptide containing a serine residue by culturing transformed cells, and a method for producing a polypeptide containing a serine residue by culturing transformed cells, characterized by reducing the formation of a byproduct polypeptide containing an O-acetylserine residue in place of a serine residue by adding at least one of histidine, methionine or glycine to the medium.
Patent IL-163225-A (IL)
Title: Process for the extraction, purification and enzymatic modification of soy 7s globulin alpha subunit for use as hypocholesterolemic agent
IPC: A23L1/305
Filed: 2004-07-27
Abstract: A purified amino-terminal polypeptide fragment of the soy β-conglycinin α′ subunit is prepared by selective extraction of defatted soy with an aqueous solution of sodium bisulfite, precipitation with ethanol, and Metal Affinity Chromatography (MAC) under denaturing conditions to obtain the α′ subunit. The α′ subunit is then enzymatically treated with chymotrypsin and subjected to further MAC to recover the amino-terminal fragment of the polypeptide (MW 28,000 Da).
Patent IL-164178-A (IL)
Title: Fusion protein comprising at least four hiv proteins and vaccine comprising said fusion protein
IPC: A61K39/00
Filed: 2004-09-21
Abstract: The invention relates to fusion proteins comprising the amino acid sequence of at least four HIV proteins selected from Vif, Vpr, Vpu, Rev, Tat and Nef or derivatives of the amino acid sequence of one or more of said proteins, wherein the fusion protein is not processed to individual HIV proteins having the natural N and C termini. The invention further concerns nucleic acids encoding said proteins, vectors comprising said nucleic acids, and methods for producing said proteins. The fusion protein, nucleic acids and vectors are usable as vaccines for the at least partial prophylaxis against HIV infections.
Patent IL-168800-A (IL)
Title: Method and apparatus for determining a set of acceptable transport format combinations
IPC: H04J13/00
Filed: 2005-05-25
Abstract: Various embodiments are provided for determining a set of acceptable transport format combinations for transmission on a current time frame. A set of acceptable modified rate power adjustment values is determined based on a maximum power level, an accumulated power commands and an initial power control command. A set of acceptable channel gain factors is determined based on the set of acceptable modified rate power adjustments values, and the set of acceptable transport format combinations is determined based on the set of acceptable channel gain factors. A possible set of modified rate power adjustment values is associated to a set of channel gain factors for determining the set of accepted channel gain factors based on various design of a transmitter chain used for transmission of data from the mobile station.
Patent IL-178206-A (IL)
Title: Scintillator material based on rare earth with a reduced nuclear background
IPC: C30B11/00
Filed: 2006-09-20
Abstract: Inorganic scintillator material of formula AnLnpX(3p+n) in which has a very low nuclear background noise and is particularly suitable as a detector scintillator for coating weight or thickness measurements, in the fields of nuclear medicine, physics, chemistry and oil exploration, and for the detection of dangerous or illicit materials.
Patent IL-182866-A (IL)
Title: Process for stabilising thiophene derivatives
Filed: 2007-04-30
Abstract: Stabilization of thiophene derivative (I) comprises reacting the thiophene derivative with basic compounds. Stabilization of thiophene derivative of formula (I) comprises treating the thiophene derivative with basic compounds. Either R 1>, R 2>1-20C-alkyl, 1-20C-oxyalkyl (both optionally substituted and interrupted by 1-5 of O or S atom) or H; or R 1>R 2>1-20C-dioxyalkylene or 1-20C-dioxyarylene (both optionally substituted), preferably substituted (1,4)-dioxane. An independent claim is included for stabilized thiophene derivative obtained by the process. [Image].
Patent IL-203354-A (IL)
Title: Heterocyclic amide compounds as protein kinase inhibitors
IPC: A61K/
Filed: 2010-01-17
Abstract: The present invention relates to novel heterocyclic amide compounds of Formula I: as disclosed herein or a pharmaceutically acceptable salt, solvate, ester, prodrug or stereoisomer thereof. Also disclosed are compositions comprising said compounds, and methods for using said compounds for treating or preventing a proliferative disease, an anti-proliferative disorder, inflammation, arthritis, a neurological or neurodegenerative disease, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral disease or a fungal disease.
Patent JP-H07312231-A (JP)
Title: Charging device for secondary battery
Inventor: ISHIGAKI TOSHINORI
IPC: H02J7/04
Filed: 1994-05-13
Abstract: PURPOSE:To provide a charging device for secondary battery in which the cycle life of a battery can be extended, and a user feels no abnormal heat by prohibiting the quick charge to the battery laid in full charge state or in a state close thereto. CONSTITUTION:The temperature of a secondary battery is detected through a thermistor, an A/D converter 41, and a battery temperature calculating part 43, and a timer 49 for measuring the elapsed time after the end of quick charge of the secondary battery is provided. This charging device also has a charge control part 50 for prohibiting the quick charge when the detected battery temperature is a prescribed value or more when the secondary battery is set to the charging device, and the elapsed time measured by the timer 49 is less than a prescribed value.
Patent JP-S59223086-A (JP)
Title: Receiver for character broadcasting
Inventor: OOSAWA HIROSHI
IPC: H04N7/03
Filed: 1983-06-02
Abstract: PURPOSE:To display program numbers on a screen even though the numbers of program are numerous with a character broadcasting receiver which makes a lateral scroll display, by performing display process of program numbers by the scroll. CONSTITUTION:Transmitted character data are once taken in a buffer memory 16. In the case of one line scroll, namely, at the time of H mode, no character data are taken in continuous 11 fields. That is to say, character data are sent to a screen by the quantity of longitudinal one line (18 dots) for one field and the next one line of character data are sent at the next field. In such a way, all the transmitted data are sent by 12 fields. A scrolled screen is obtained by shifting leftward by one bit for one field. Transfer to a pattern memory is performed in such a way that the content of the buffer memory 16 is shifted leftward by one bit and a carry is stored at the right end of a pattern memory 17 and, at same time, the pattern memory 17 is shifted leftward by one bit. Such operation is performed to all addresses of the pattern memory 17 in the same way.
Patent JP-H0646118-A (JP)
Title: Final data number recording system
Inventor: KOBAYASHI YOSHIKAZU
IPC: H04M1/56
Filed: 1992-04-21
Abstract: PURPOSE:To attain the effective use of a memory storing a dial number by providing a function erasing the dial number written as the youngest number in a memory control part. CONSTITUTION:A dial number memory part 2 has areas (1) to (3) storing three dial numbers and stores the dial number by the control of the memory control part 3, which records the dial number of an individual call outputted from a dial button dipressing part 1 in the (1) of the dial number memory part 2. The dial number recorded in the area (1) is transferred to the area (2), that in the area (2) is moved to the area (3) and the oldest recorded dial number in the area (3) is abandoned/erased. Besides, at the time of being required erasing from a memory calling part 4, the dial number recorded in the area being connected (called) to the memory calling part 4 is erased by the reception of a next disconnecting requirement so as to successively move the dial numbers recorded in the area of old number to the side of a young number. An automatic transmission part 6 automatically transmits the received dial number to a communication channel.
Patent JP-H01272548-A (JP)
Title: Method for separating pyruvic acid
Inventor: ONO HIROSHI
IPC: C07C51/48
Filed: 1988-04-25
Abstract: PURPOSE:To efficiently extract and separate high-purity pyruvic acid of excellent quality useful as a raw material for producing various medicines or amino acids from an aqueous solution containing the pyruvic acid in simple operation by using isopropyl acetate as an extracting solvent. CONSTITUTION:Isopropyl acetate in a volume of preferably 0.1-50times, especially preferably 0.5-5times based on water in an aqueous solution normally containing pyruvic acid is added to the aqueous solution containing the pyruvic acid at normally 10-80 deg.C, preferably 15-45 deg.C and the resultant mixture is stirred, distilled and then separated under ordinary pressure or more preferably under a reduced pressure of about 50-700mmHg to remove the isopropyl acetate. Thereby, the aimed pyruvic acid is extracted and separated by batch or continuous operation. Furthermore, the resultant pyruvic acid provides small load and loss thereof in a purification step.
Patent JP-S5490964-A (JP)
Title: Manufacture for fluorescnet display tube
Inventor: YANAGISAWA GEN
IPC: H01J31/12
Filed: 1975-08-19
Abstract: PURPOSE: To increase the reliability, by enabling to drive the fluorescent display tube of multi-digits with a low voltage, through coating fluorescent substance on the underground electrode layer via the intermediate conductive layer having good adaptability.  
     CONSTITUTION: The thick film feeding line 11 connected to the anode elements E1,E2... is formed on the insulation substrate 10 consisting of ceramic, insulation layer 12 is coated on the feeding line 11, and the underground electrode 13 of the anode elements E1,E2... connected with the ridge of the feeding line 11 through the through hole 14 of insulation layer is provided partly on it. The intermediate layer 15 is formed by coating and baking the chemicals taking amorphous carbon as major component and slightly mixing organic binder on the surface of the underground electrode 13 with spray or screen print. The fluorescent substance 16 of ZnO;Zn is coated on the intermeidate layer, forming the anode elements E1,E2... . Thus, the storage charge in the fluorescent substance flows through the intermediate layer quickly and low voltage drive can be made. 
     COPYRIGHT: (C)1979,JPO&Japio
Patent JP-S581313-A (JP)
Title: Variable equalizer
Inventor: SHINOZUKA TAKASHI
IPC: H04B3/14
Filed: 1981-06-26
Abstract: PURPOSE:To realize a board type equalizer which is easily controlled and suitable for integration, by connecting a variable gain circuit to an amplifying circuit with frequency characteristics to be equalized. CONSTITUTION:The difference signal obtained by subtracting the output signal of an amplifier 3 with transmission characteristics Q from an input signal Si is inputted to an amplifying circuit 2 with transmission characteristics Q and an amplifying circuit 1 with transmission characteristics P, and the outputs of those circuits 1 and 2 are added by a synthesizing circuit 5 to obtain an output signal So. The transmission characteristics P are regarded as frequency characteristics to be equalized, and the transmission characteristics Q are as variable gain charateristics. Adding the frequency characteristics and variable gain  characteristics to the overall characteristics T by the transmission characteristics P and Q realized characteristics of a board type. Even when the transmission characteristics P and Q are exchanged with each other, the characteristics  of the board type are realized.